Tekturna was launched by Novartis and was commonly called Tektuna by the sales force. It is an expensive brand name antihypertensive that offered no advantage over a flooded market of generic antihypertensives in numerous drug classes. Good luck with that one.
Ask anyone at Novartis who sold this product. They will not be surprised by this comment. Expensive drug in a generic therapeutic area with no coverage.
